| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 津药达仁堂集团股份有限公司是天津医药集团控股的A+S股上市公司。 公司以绿色中药为核心，集药材种植加工、医药商业、大健康产业于一体，是全产业链、多剂型、多品种的国家级高新技术企业。 津药达仁堂是传统中药精粹的传承者，达仁堂、乐仁堂、京万红袭500余年“乐家老铺”裔脉；隆顺榕开卫药之先，历190年依然生机勃勃。 公司现拥有达仁堂、隆顺榕、乐仁堂、京万红4家中华老字号企业；5个国家级非物质文化遗产项目、12个天津市级非物质文化遗产项目；6个中国驰名商标等，无不生动展现津药达仁堂厚重的历史积淀和丰富的发展成果。 津药达仁堂是我国中药现代化的开拓者，是中国现代中药制剂技术的摇篮，新中国诸多中药新剂型诞生于此：第一个规模化生产的中药滴丸制剂产品——速效救心丸、第一个中成药片剂——银翘解毒片、第一个中成药酊剂——藿香正气水、第一家通过GMP认证的中药制药企业—第六中药厂等，敢为人先成就津药达仁堂成为中国现代中药品种资源丰富的企业集团，拥有22个剂型、599个药品批准文号、122个独家生产品种，包括国 家机密品种速效救心丸和国家秘密品种京万红软膏，诸多开先河、补空白、里程碑式的现代中药广受人民赞誉。 津药达仁堂是做大做强祖国医药的坚定拥护者，主动响应国家“十四五”规划号召，2022年5月18日，正式更名为“津药达仁堂集团股份有限公司”，开启公司发展新纪元。“十四五”期间，公司坚定推进“1+5”战略规划”，以品牌为引领，突出“三核九翼”，围绕心脑血管、皮肤创面修复、精品国药健康养生3大核心，构建以“速效救心丸”、“京万红软膏”和达仁堂品牌养生健康品类为代表的“核心战力”群；强化呼吸、消化、风湿骨痛等9类产品线协调发展，努力成为现代中药引领者，打造航向蓝海的中药新“航母”，谱写属于津药达仁堂的新时代绚丽华章。 | ||||||||||||||||||||||||
| Main Business | 中成药，中药材，化学原料及制剂，生物医药，营养保健品研发制造及医药商业 | ||||||||||||||||||||||||
| Legal Representative | 陈洪 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 焦艳 | ||||||||||||||||||||||||
| Solicitors | 北京市君泽君律师事务所 | ||||||||||||||||||||||||
| Auditors | 瑞华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 022-27020892 | ||||||||||||||||||||||||
| Fax No | 022-27020892 | ||||||||||||||||||||||||
| Website | www.jydrt.com.cn | ||||||||||||||||||||||||
| drt600329@163.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 06/06/2001 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 2.770 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 4.790 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 9.219 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 22.712B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |